J Korean Med Sci.  2010 Feb;25(2):333-335. 10.3346/jkms.2010.25.2.333.

Use of Aripiprazole in Clozapine Induced Enuresis: Report of Two Cases

Affiliations
  • 1Department of Psychiatry, Incheon Christian Hospital, Incheon, Korea.
  • 2Department of Psychiatry, Inha University Hospital and College of Medicine, Incheon, Korea. kce320@inha.ac.kr

Abstract

This report describes the efficacy of combined use of aripiprazole in the treatment of a patient with clozapine induced enuresis. Aripiprazole acts as a potential dopamine partial agonist and the dopamine blockade in the basal ganglia might be one of the causes of urinary incontinence and enuresis. We speculate that aripiprazole functioned as a D2 agonist in hypodopaminergic state of basal ganglia caused by clozapine and maintained dopamine level that would improve enuresis ultimately.

Keyword

Clozapine; Enuresis; Aripiprazole; Dopamine

MeSH Terms

Adult
Antipsychotic Agents/*adverse effects
Clozapine/*adverse effects
Dopamine/metabolism
Dopamine Agonists/*therapeutic use
Drug Therapy, Combination
Enuresis/chemically induced/*drug therapy
Humans
Male
Middle Aged
Piperazines/*therapeutic use
Quinolones/*therapeutic use
Schizophrenia, Paranoid/drug therapy
Antipsychotic Agents
Dopamine Agonists
Piperazines
Quinolones
Clozapine

Reference

1. Safferman A, Lieberman JA, Kane JM, Szymanski S, Kinon B. Update on the clinical efficacy and side effects of clozapine. Schizophr Bull. 1991. 17:247–261.
Article
2. Lin CC, Bai YM, Chen JY, Lin CY, Lan TH. A retrospective study of clozapine and urinary incontinence in Chinese in-patients. Acta Psychiatr Scand. 1999. 100:158–161.
Article
3. Aronowitz JS, Safferman AZ, Lieberman JA. Management of clozapine-induced enuresis. Am J Psychiatry. 1995. 152:472.
4. Poyurovsky M, Modai I, Weizman A. Trihexyphenidyl as a possible therapeutic option in clozapine-induced nocturnal enuresis. Int Clin Psychopharmacol. 1996. 11:61–63.
Article
5. Fuller MA, Borovicka MC, Jaskiw GE, Simon MR, Kwon K, Konicki PE. Clozapine-induced urinary incontinence: incidence and treatment with ephedrine. J Clin Psychiatry. 1996. 57:514–518.
Article
6. Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol. 1994. 9:207–209.
Article
7. Kang BJ. One case of clozapine induced enuresis. J Korean Soc Biol Ther Psychiatry. 1996. 2:135–138.
8. Praharaj SK, Arora M. Amitriptyline for clozapine-induced nocturnal enuresis and sialorrhoea. Br J Clin Pharmacol. 2007. 63:128–129.
Article
9. Chee IS, Park CB, Lee SW, Wang SK, Shin SC. Oxybutynin hydrochloride in 3 cases of clozapine induced nocturnal enuresis. J Korean Neuropsychiatr Assoc. 2000. 39:955–959.
10. Kantrowitz JT, Srihari VH, Tek C. Three cases of risperidone-induced enuresis. Schizophr Res. 2006. 84:174–175.
Article
11. Ambrosini PJ. A pharmacological paradigm for urinary incontinence and enuresis. J Clin Psychopharmacol. 1984. 4:247–253.
Article
12. Green B. Focus on aripiprazole. Curr Med Res Opin. 2004. 20:207–213.
13. Nurnberg HG, Ambrosini PJ. Urinary incontinence in patients receiving neuroleptics. J Clin Psychiatry. 1979. 40:271–274.
14. Took KJ, Buck BJ. Enuresis with combined risperidone and SSRI use. J Am Acad Child Adolesc Psychiatry. 1996. 35:840–841.
Article
15. Rosenberg RN, Nyhan WL, Bay C, Shore P. Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology. 1976. 26:703–714.
Article
16. Sanders WL, Dunn TL. Creutzfeldt-Jakob disease treated with amantadine; a report of two cases. J Neurol Neurosurg Psychiatry. 1973. 36:581–584.
17. Testa R, Guarneri L, Poggesi E, Angelico P, Velasco C, Ibba M, Cilia A, Motta G, Riva C, Leonardi A. Effect of several 5-hydroxytryptamine( 1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635. J Pharmacol Exp Ther. 1999. 290:1258–1269.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr